Found 30 matching trials
REP 2139-Mg and REP 2165-Mg Combination Therapy in Chronic Hepatitis B Infection PHASE2 NAPs have been previously shown to clear serum hepatitis B virus surface an...
Show More Location
Infectious Clinical Hospital (n.a. Toma Ciorba) Department 5
Learn More & Join Trial
Addition of PegIFN Alfa-2a to CHB Patients Treated With Nucleot(s)Ides PHASE4 This study evaluates whether PegIFN alfa-2a add on can improve CHB patients...
Show More Location
Multiple Locations
Learn More & Join Trial
Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis B PHASE3 This clinical trial compares the efficacy of peginterferon plus tenofovir f...
Show More Location
Cedars Sinai Medical Center
Learn More & Join Trial
HEllenic Multicenter ReAl-life CLInical Study for Bulevirtide Therapy in Chronic Hepatitis D: HERACLIS-BLV N/A This study aims to assess the efficacy and safety of bulevirtide (BLV) in c...
Show More Location
Department of Gastroenterology, Medical School of National & Kapodistrian University of Athens, General Hospital of Athens "Laiko";
Learn More & Join Trial
Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis B PHASE1 The purpose of this protocol is to obtain pharmacodynamic and pharmacokinet...
Show More Location
Monash University
Learn More & Join Trial
HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta Hepatitis PHASE2 Randomized, double blind study comparing the efficacy of pegylated interfer...
Show More Location
Charité Campus Virchow-Klinikum, Med. Klinik für Gastroenterologie und Hepatologie
Learn More & Join Trial
The Investigation of Peginterferon Alfa-2a on Optimal in Chronic Hepatitis B Patients Who Have a High Risk of HCC PHASE4 The CHB subjects who are cirrhosis, will be randomized to two groups.
The ...
Show More Learn More & Join Trial
A Study of Early Immunologic Response in Asian Patients With Chronic Hepatitis B, Treated With Pegasys (Peginterferon Alfa-2a (40KD)), Nucleoside Analogues, or Both PHASE1 This open-label, randomized, parallel-arm study will assess the early immun...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D. PHASE3 This randomized, single blind study will compare the antiviral effect of Pe...
Show More Location
Ankara University Medical Facility; Hepatology Department
Learn More & Join Trial
The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection PHASE4 The current study is a prospective, randomized, open, multi-center investig...
Show More Learn More & Join Trial